Thoracic Surgery Devices Market Size, Share & Forecast 2026-2033

Overview

The Global Thoracic Surgery Devices Market size was valued at USD 830.9 million in 2025 and is expected to reach USD 1,344.4 million by 2033, growing with a CAGR of 6.2% during the forecast period 2026-2033. The increasing burden of thoracic diseases is a major driver of the thoracic surgery devices market, as the rising incidence of lung cancer, chronic obstructive pulmonary disease (COPD), and other pulmonary disorders is increasing the demand for surgical diagnosis and treatment. Many thoracic conditions require procedures such as lung cancer surgery, lobectomies, biopsies, and minimally invasive thoracic surgeries, all of which depend on advanced thoracic surgical devices, including surgical staplers, energy systems, endoscopes, and robotic-assisted platforms. According to the Union for International Cancer Control (UICC), global lung cancer cases are projected to reach nearly 3 million new cases annually by 2030, while the World Health Organization (WHO) projects that COPD will become the third leading cause of death worldwide by 2030. These trends are significantly increasing the volume of thoracic surgical procedures and driving demand for innovative surgical technologies.

The growing prevalence of thoracic diseases is also encouraging healthcare providers to adopt minimally invasive and robotic-assisted surgical techniques that improve clinical outcomes, reduce postoperative complications, and shorten hospital stays. Early diagnosis through improved screening programs is leading to a greater number of patients undergoing surgical intervention at treatable stages, further increasing the utilization of thoracic surgery devices. In addition, continuous advancements in surgical instrumentation, imaging technologies, and precision-guided procedures are enabling surgeons to perform increasingly complex thoracic operations with greater accuracy and safety. As the global burden of respiratory diseases continues to rise, the demand for advanced thoracic surgery devices is expected to grow steadily.

Drivers

Growing Adoption of Robotic-Assisted Surgery

The growing adoption of robotic-assisted surgery is a major driver of the thoracic surgery devices market as healthcare providers increasingly seek technologies that enhance surgical precision, improve visualization, and support minimally invasive procedures. Robotic-assisted systems enable surgeons to perform complex thoracic interventions with greater dexterity, stability, and control, resulting in smaller incisions, reduced blood loss, fewer complications, faster patient recovery, and shorter hospital stays. The integration of advanced computing, imaging, and navigation technologies is further improving procedural accuracy from diagnosis through surgical treatment.

Reflecting this trend, in March 2025, Johnson & Johnson MedTech received U.S. FDA 510(k) clearance for the MONARCH QUEST platform, which incorporates NVIDIA-accelerated computing to provide 260% greater real-time computational power for robotic bronchoscopy navigation. By strengthening the integration of bronchoscopy with downstream surgical planning, the platform enables more precise diagnosis and lung resection workflows, demonstrating how continuous innovation in robotic-assisted technologies is driving demand for advanced thoracic surgery devices.

Continuous Innovations in VATS

Continuous innovations in video-assisted thoracoscopic surgery (VATS) are a major driver of the thoracic surgery devices market by accelerating the adoption of minimally invasive surgical techniques that improve patient outcomes while increasing demand for advanced thoracic surgical instruments. Advances in high-definition imaging, endoscopic visualization, surgical staplers, energy devices, and precision instrumentation have made VATS increasingly effective for treating lung cancer and other thoracic conditions, enabling surgeons to perform complex procedures through smaller incisions with greater accuracy. These innovations contribute to reduced postoperative pain, fewer complications, shorter hospital stays, faster recovery, and improved quality of life compared with conventional open surgery.

Supporting this trend, a September 2025 meta-analysis presented at the IASLC World Conference on Lung Cancer (WCLC) 2025, based on individual patient data from 1,185 patients across three randomized clinical trials, found that VATS for early-stage non-small cell lung cancer reduced the overall risk of death by 21% compared with open lobectomy while maintaining comparable disease-free survival. These findings reinforce VATS as the preferred surgical approach when technically feasible and are driving greater adoption of specialized thoracic surgery devices designed for minimally invasive procedures.

Restraint

High Capital Expenditure

High capital expenditure remains a significant restraint for the thoracic surgery devices market because the acquisition, installation, and maintenance of advanced surgical systems require substantial financial investment. Robotic-assisted surgical platforms, endoscopic imaging systems, high-definition video-assisted thoracoscopic surgery (VATS) equipment, energy devices, and specialized surgical instruments involve high upfront costs, in addition to ongoing expenses for maintenance, software upgrades, disposable instruments, and surgeon training. These financial barriers can limit adoption, particularly among small and mid-sized hospitals, ambulatory surgical centers, and healthcare facilities in developing regions with constrained budgets. Furthermore, uncertainty regarding reimbursement for advanced thoracic procedures may reduce the return on investment for healthcare providers, delaying purchasing decisions. As a result, the high cost of advanced thoracic surgery technologies can slow market penetration despite their proven clinical and operational benefits.

Thoracic Surgery Devices Market Trends & Opportunities

AI-Assisted 3D Surgical Planning

The integration of Artificial Intelligence (AI) and 3D surgical planning is emerging as a key trend in the thoracic surgery devices market, enabling surgeons to improve preoperative planning, enhance intraoperative precision, and optimize patient outcomes. AI-powered algorithms combined with three-dimensional anatomical reconstruction allow clinicians to accurately visualize complex pulmonary structures, identify anatomical variations, and simulate surgical procedures before entering the operating room. This supports more precise resections, reduces procedural risks, and improves decision-making during minimally invasive thoracic surgeries.

Reflecting this trend, a February 2025 published study titled "Artificial Intelligence-Assisted Surgical Simulation System Based on Non-Enhanced Computed Tomography Images in Thoracoscopic Pulmonary Segmentectomies" introduced the LungDimensionGo V1.0 platform, which generates accurate 3D lung models from non-enhanced CT images for preoperative planning and intraoperative navigation. Compared with conventional planning methods, the AI-assisted system reduced model reconstruction and operative times, minimized blood loss, lowered postoperative complications, and improved patient recovery, highlighting the growing role of AI and advanced surgical planning technologies in driving innovation within the thoracic surgery devices market.

Increasing Use of Disposable Surgical Devices and Single-Use Devices

The increasing use of disposable and single-use devices is an important trend in the thoracic surgery devices market as healthcare providers seek to reduce the risk of cross-contamination, improve operating room efficiency, and ensure consistent surgical performance. Single-use surgical devices eliminate the need for cleaning, sterilization, and reprocessing, helping hospitals lower infection risks, streamline workflows, and comply with stringent infection prevention protocols. In minimally invasive thoracic procedures, disposable instruments also provide reliable performance and reduce maintenance requirements associated with reusable equipment.

Reflecting this trend, in May 2024, Lexington Medical received U.S. FDA clearance for its AEON Powered Stapling System, a single-patient-use powered endoscopic stapler designed for minimally invasive procedures, including thoracic surgery. The device delivers more consistent staple formation, reduces the firing force required by surgeons, and eliminates the need to reprocess reusable stapler handles between procedures, demonstrating how single-use technologies are improving surgical efficiency, patient safety, and procedural outcomes while driving growth in the thoracic surgery devices market.

Segment Analysis

The global thoracic surgery devices industry is segmented based on procedure type, product type, indication, end user and region.

Expanded the use of VATS Across a Wide Range of Thoracic Conditions

Video-assisted thoracoscopic surgery market segment held the largest market revenue share of more than 48% in the year 2025. The VATS segment is growing in the thoracic surgery devices market due to the increasing preference for minimally invasive procedures that offer reduced postoperative pain, shorter hospital stays, faster recovery, and lower complication rates compared with traditional open thoracic surgery. Advances in endoscopic imaging, surgical stapling systems, and thoracoscopic instruments have expanded the use of VATS across a wide range of thoracic conditions, including lung cancer, pneumothorax, mediastinal diseases, and thoracic trauma.

Supporting this trend, a January 2024 published review titled "Video-Assisted Thoracoscopic Surgery (VATS) in Trauma: A Narrative Review" highlighted the growing clinical role of VATS in managing retained hemothorax, acute hemothorax in hemodynamically stable patients, persistent pneumothorax, hemopericardium, and diaphragmatic injuries. The review concluded that the expanding body of clinical evidence demonstrates VATS to be a safe and effective minimally invasive approach that improves the management of both acute thoracic trauma and long-term injury-related complications, while ongoing research continues to broaden its applications, driving demand for specialized thoracic surgery devices.

Increasing Adoption of Robotic-Assisted Surgery

The robotic platforms segment held the largest market revenue share of 32% in 2025, due to the increasing adoption of robotic-assisted surgery for complex cardiothoracic procedures that require enhanced precision, dexterity, and visualization. Robotic systems enable surgeons to perform minimally invasive procedures through small incisions while offering improved instrument control, three-dimensional visualization, and greater surgical accuracy, leading to reduced blood loss, fewer complications, shorter hospital stays, and faster patient recovery.

Continuous expansion of robotic platform capabilities is further accelerating their adoption across thoracic surgery. In January 2026, Intuitive received U.S. FDA clearance for the da Vinci 5 system to perform selected cardiac procedures, including mitral valve repair and internal mammary artery (IMA) mobilization for cardiac revascularization. This approval significantly expands the platform's use in complex cardiothoracic surgeries, demonstrating the growing versatility of robotic-assisted systems and reinforcing the increasing demand for robotic platforms in the thoracic surgery devices market.

Increasing Detection of Mediastinal Masses Through Advanced Imaging

By indication, the mediastinal tumors segment is the fastest-growing segment in the thoracic surgery devices market due to increasing detection of mediastinal masses through advanced imaging, rising adoption of minimally invasive surgical techniques, and growing demand for precise thoracic surgical interventions. Surgical resection remains the primary treatment for many mediastinal tumors, driving the use of specialized thoracic surgery devices such as endoscopic instruments, energy devices, staplers, and video-assisted thoracoscopic surgery (VATS) systems. Advances in minimally invasive approaches are enabling surgeons to manage even large and complex mediastinal tumors with improved safety and clinical outcomes.

According to the National Institutes of Health (NIH), nearly two-thirds of mediastinal tumors are diagnosed incidentally during chest CT imaging performed for unrelated clinical conditions. The growing use of advanced imaging modalities and lung cancer screening programs is increasing the detection of asymptomatic mediastinal masses at earlier stages, creating greater demand for thoracic surgical interventions and specialized surgical devices.

Supporting this trend, a January 2026 published study titled "Management of Large Anterior Mediastinal Mass by Video-Assisted Thoracoscopic Surgery" evaluated eight patients with anterior mediastinal masses measuring 5–12 cm and reported 100% complete (R0) tumor resection, low average blood loss (180 mL), no mortality, no recurrence, and favorable outcomes over an average 14-month follow-up. The study also demonstrated that a dual VATS approach provided additional benefits for tumors with bilateral extension, reinforcing the growing role of minimally invasive thoracic surgery and driving demand for advanced thoracic surgery devices in the mediastinal tumors segment.

Geographical Penetration

North America Thoracic Surgery Devices Market: Driven by Strong Clinical Adoption of Next-Generation Thoracic Surgery Solutions

North America held the largest market revenue share of 37% in the year 2025, due to the increasing prevalence of thoracic diseases, a rising cancer burden, and the widespread adoption of advanced minimally invasive surgical technologies. The growing number of patients requiring surgical treatment for lung cancer, thoracic trauma, and chronic respiratory diseases is increasing demand for specialized devices such as surgical staplers, thoracoscopes, fixation systems, energy devices, and robotic-assisted platforms. According to the American Cancer Society, more than 16.9 million Americans were living with a history of cancer as of January 1, 2019, and this number is projected to exceed 22.1 million by 2030. In addition, chronic obstructive pulmonary disease (COPD) remains one of the top 10 leading causes of death in the United States, further contributing to the growing need for thoracic surgical interventions and advanced surgical devices.

The region is also benefiting from rapid technological innovation and strong clinical adoption of next-generation thoracic surgery solutions. In January 2026, Able Medical announced that its Valkyrie Thoracic Fixation System had been used in more than 10,000 procedures across the United States, demonstrating broad surgeon acceptance of advanced thoracic fixation technologies. The system's PEEK-based design provides intraoperative adaptability and improved surgical workflow efficiency, enabling greater procedural flexibility and supporting repeat clinical use. Combined with North America's advanced healthcare infrastructure, high procedural volumes, favorable reimbursement environment, and continuous investment in surgical innovation, these developments are driving sustained growth of the thoracic surgery devices market in the region.

Europe Thoracic Surgery Devices Market: Driven by High Lung Cancer Burden and Advanced Surgical Technologies

The thoracic surgery devices market in Europe is growing due to the increasing adoption of minimally invasive surgical techniques, advancements in surgical planning technologies, and rising demand for precision-based procedures. European healthcare systems are increasingly integrating technologies such as video-assisted thoracic surgery (VATS), virtual reality (VR), and advanced imaging solutions to improve surgical accuracy, reduce complications, and enhance patient recovery.

Europe continues to experience a high burden of thoracic diseases, supported by an aging population and a significant incidence of lung cancer across countries such as Germany, France, Italy, and the United Kingdom. According to the European Cancer Information System (ECIS), lung cancer remains one of the most commonly diagnosed cancers in Europe, increasing the demand for thoracic surgical procedures and advanced surgical technologies across the region.

According to a September 2024 research paper titled "Virtual Reality-Based Preoperative Planning for Optimized Trocar Placement in Thoracic Surgery: A Preliminary Study", researchers developed the first VR-based preoperative planning tool for optimizing trocar placement in VATS. The system uses patient-specific anatomy, surgical principles, and interactive VR visualization to help surgeons determine optimal trocar positions for right upper lung lobectomy. Preliminary testing demonstrated that the tool was efficient, reliable, and user-friendly, highlighting the growing role of digital technologies in improving thoracic surgical workflows and supporting future surgical applications.

The market is further expanding due to continuous product innovation and the introduction of advanced cardiothoracic devices across Europe. In October 2025, Medtronic launched the Avalus Ultra Bioprosthesis valve in Western Europe for minimally invasive aortic tissue replacement procedures, building on ten years of clinical data. The company also introduced the Penture Left Atrial Appendage (LAA) Exclusion System across Europe, featuring a recapturable, repositionable, and redeployable LAA clip, along with the VitalFlow Extracorporeal Membrane Oxygenation (ECMO) system for acute cardiopulmonary support. These innovations reflect the region’s strong focus on advanced surgical solutions, improved procedural outcomes, and next-generation technologies, driving continued growth of the thoracic surgery devices market in Europe.

Asia-Pacific Thoracic Surgery Devices Market: Driven by the Higher Demand for Thoracic Procedures

The Asia-Pacific region is the fastest-growing market for thoracic surgery devices due to the rising burden of thoracic diseases, expanding healthcare infrastructure, increasing adoption of minimally invasive surgical techniques, and growing investments in advanced medical technologies. Countries such as Japan, China, and India are experiencing higher demand for thoracic procedures due to the increasing prevalence of lung cancer, respiratory disorders, and aging populations. Improvements in healthcare access, expansion of specialty hospitals, and government initiatives to modernize medical facilities are accelerating the adoption of advanced surgical devices, including robotic platforms, electrosurgical systems, and video-assisted thoracoscopic surgery (VATS) technologies. The expansion of insurance coverage for innovative surgical technologies is also improving access to advanced procedures across the region.

Technological advancements and strategic product launches are further strengthening market growth in Asia-Pacific. The Medicaroid Corporation Hinotori Surgical Robot System received Japanese insurance coverage expansion for thoracic surgery in 2024, supporting broader clinical adoption of robotic-assisted procedures and increasing access to precision surgical technologies. Additionally, Medtronic launched the Valleylab FT10 Electrosurgical Generator and Valleylab FT10 Vessel Sealing Generator in India in 2025, providing surgeons with advanced tools designed to improve surgical precision, efficiency, and operating room workflows. These developments demonstrate the region’s growing focus on adopting next-generation surgical solutions, enhancing clinical capabilities, and meeting the increasing demand for safer and more effective thoracic procedures, thereby driving rapid expansion of the thoracic surgery devices market in Asia-Pacific.

South America Thoracic Surgery Devices Market: Driven by Rising Demand for Minimally Invasive Surgical Procedures

The thoracic surgery devices market in South America is growing due to the increasing prevalence of respiratory diseases, rising demand for minimally invasive surgical procedures, and gradual improvements in healthcare infrastructure across the region. The growing incidence of lung cancer, chronic respiratory conditions, and thoracic trauma is increasing the need for advanced surgical solutions such as thoracoscopic instruments, surgical staplers, energy devices, and fixation systems. Investments in healthcare modernization, expansion of specialty hospitals, and improved access to advanced diagnostic and surgical technologies are encouraging the adoption of more sophisticated thoracic procedures.

Brazil accounts for the largest healthcare market in Latin America, while countries such as Argentina with Colombia continue expanding oncology services and tertiary care capacity to improve access to specialized thoracic procedures. These investments are increasing demand for advanced surgical devices used in minimally invasive thoracic interventions.

Additionally, the growing awareness among healthcare providers regarding the benefits of minimally invasive approaches, including reduced recovery time, lower complication rates, and improved patient outcomes, is supporting the use of video-assisted thoracoscopic surgery (VATS) and other advanced techniques. As South American countries continue to strengthen their healthcare systems and adopt innovative surgical technologies, demand for thoracic surgery devices is expected to increase steadily across the region.

Middle East & Africa Thoracic Surgery Devices Market : Driven by Improving Access to Advanced Surgical Technologies

The thoracic surgery devices market in the Middle East & Africa is growing due to the rising burden of respiratory diseases, increasing healthcare investments, and improving access to advanced surgical technologies. The growing prevalence of conditions such as lung cancer, chronic respiratory disorders, and thoracic injuries is driving demand for specialized surgical devices, including thoracoscopic instruments, surgical staplers, energy systems, and minimally invasive surgery solutions.

Governments across the region are investing in healthcare infrastructure development, establishing advanced medical centers, and expanding access to specialized surgical care as part of broader healthcare modernization initiatives. Saudi Arabia's Vision 2030 healthcare transformation program, the UAE's continued investments in advanced specialty hospitals, and expanding oncology and respiratory care services across South Africa are improving access to complex thoracic surgical procedures. These initiatives are supporting wider adoption of advanced thoracic surgery devices across the region.

In addition, the adoption of minimally invasive techniques, improved diagnostic capabilities, and collaborations with global medical device companies are supporting the introduction of advanced thoracic surgery technologies. As healthcare systems in the Middle East & Africa continue to enhance surgical capabilities and focus on improving patient outcomes, the demand for innovative thoracic surgery devices is expected to grow steadily.

Key Developments

·         In March 2026, Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd.  announced that the United States Food and Drug Administration (FDA) has granted Breakthrough Device Designation to its Hector™ Multi-Branch Thoracic Stent Graft System, an investigational device designed for the endovascular treatment of complex aortic arch disease.  The FDA Breakthrough Devices Program is intended to facilitate development and review of medical devices that may provide more effective treatment or diagnosis for life-threatening or irreversibly debilitating conditions

·         In March 2026, Olympus launched its VISERA ELITE III 4K surgical imaging platform with AI-powered pre-operative planning tools that convert CT and MRI scans into 3D thoracic models, improving precision in lung cancer and thoracic procedures.

·         In June 2025, Johnson & Johnson announced the launch of its ETHICON 4000 Stapler in the U.S. This advanced surgical stapler is designed to address tissue complexities and enhance staple line integrity, aiming to reduce the risk of surgical leaks and bleeding complications across various medical specialties.